1. A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease. Issue 2 (5th August 2015) Authors: Boschetti, G; Assaad, S; Balme, B; Boyer, S; Flourié, B; Nancey, S Journal: Gut Issue: Volume 65:Issue 2(2016) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0745 Subclinical atherosclerosis evolution in psoriatic arthritis patients treated with anti-tnf alpha: 5 years follow up. (15th June 2017) Authors: Ortolan, A; Puato, M; Boschetti, G; Lorenzin, M; Hoxha, A; Punzi, L; Ramonda, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP050 Influence of disease location on vedolizumab efficacy in inflammatory bowel disease: a real-life multicentre experience. (16th January 2018) Authors: Pestour, S; Nancey, S; Charlois, A L; Bonaz, B; Flourie, B; Boschetti, G; Mathieu, N Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DOP33 Role of adherent and invasive E. coli in Crohn's Disease: Lessons from the postoperative recurrence model. (21st January 2022) Authors: Buisson, A; Sokol, H; Hammoudi, N; Nancey, S; Treton, X; Nachury, M; Fumery, M; Hébuterne, X; Rodrigues, M; Hugot, J P; Boschetti, G; Stefanescu, C; Wils, P; Seksik, P; Le Bourhis, L; Bezault, M; Sauvanet, P; Pereira, B; Allez, M; Barnich, N Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i082 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P047 The ATG16L1 T300A polymorphism in Crohn's Disease patients leads to abnormal autophagy flux in dendritic cells. (27th May 2021) Authors: Quiniou, G; Dinet, O; Cervantes, O; Verdet, M; Boschetti, G; Viret, C; Nancey, S; Faure, M; Rozieres, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P115 Monitoring faecal calprotectin at 3 months post-surgery is useful to predict further postoperative endoscopic recurrence in Crohn's disease. (25th January 2019) Authors: Veyre, F; Nancey, S; Meunier, C; Roblin, X; Cuerq, C; Mialon, A; Danion, P; Chauvenet, M; Flourie, B; Boschetti, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P144 Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study. (30th January 2023) Authors: Meunier, C; Monte, C; Hadjisavvas, H; Rozieres, A; Roblin, X; Venturin, C; Gay, C; Flourie, B; Boschetti, G; Danion, P; Mathieu, N; Charlois, A L; Faure, M; Nancey, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P226 Systematic review with meta-analysis of individual data: impact of cut-off values on the performance of faecal calprotectin to detect endoscopic recurrence after intestinal resection in patients with Crohn's disease. (25th January 2019) Authors: Kirchgesner, J; Boschetti, G; Buisson, A; Yamamoto, T; Domenech, E; Nancey, S; Peyrin-Biroulet, L; Uzzan, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P465 Is golimumab serum level predictive of clinical remission after intensification for loss of response in patients with ulcerative colitis?. (21st January 2022) Authors: Fumery, M; Nancey, S; Filippi, J; Altwegg, R; Hebuterne, X; Boschetti, G; Veyrard, P; Yzet, C; Paul, S; Roblin, X Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P494 Impact of early optimization of ustekinumab on mid-term targets in severe Crohn's disease: THE MUST study. (30th January 2023) Authors: Abdelmoula, A; Chateau, T; Hupe, M; Boschetti, G; Roblin, X; Nancey, S; Mathieu, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗